HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Christine L. Lau Irving L. Kron Victor E. Laubach Gorav Ailawadi Permission Requests Google Scholar Articles by Lau, C. L. Articles by Linden, J. PubMed Articles by Lau, C. L. Articles by Linden, J. Related Collections Lung - transplantation

---

Original Articles: General Thoracic

The Role of Adenosine A_2A Receptor Signaling in Bronchiolitis Obliterans

^a Department of Surgery, University of Virginia Health System, Charlottesville, Virginia
^b Department of Pathology, University of Virginia Health System, Charlottesville, Virginia
^c Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia

Accepted for publication June 15, 2009.

^_* Address correspondence to Dr Lau, Department of Surgery, PO Box 800679, Charlottesville, VA 22908-0679 (Email: cll2y{at}virginia.edu).

Presented at the Poster Session of the Forty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Francisco, CA, Jan 26–28, 2009

Background: Binding of adenosine to the anti-inflammatory Gs-coupled adenosine 2A receptor (A_2AR) inhibits the activity of most inflammatory cells. Extensive preclinical evidence exists for the use of A_2AR agonists in the prevention of acute ischemia-reperfusion injury. Activation of A_2ARs on lymphocytes and antigen-presenting cells also attenuates the alloimmune response. Because ischemia-reperfusion injury and alloimmunity are risk factors for the development of bronchiolitis obliterans (BO), the objective of this study was to determine the effect of A_2AR signaling on tracheal rejection in a mouse model of BO.

Methods: A non-revascularized heterotopic tracheal model across a total alloantigenic mismatch was used to study A_2AR signaling in a mouse model of BO. Tracheal transplants were performed using Balb/c donors into wild-type or A_2AR knockout C57BL/6 recipient mice. Another group of Balb/c transplants into C57BL/6 recipients were also treated with a selective A_2AR agonist. Tracheas were assessed at 3, 7, 12, 21, and 28 days after transplantation by hematoxylin and eosin staining, immunohistochemical staining, and collagen staining.

Results: Compared with allograft tracheas in wild-type recipients, allografts in A_2AR knockout recipients had increased inflammation and more severe BO development. Recipient wild-type mice treated with a selective A_2AR agonist were significantly protected from lymphocyte infiltration and luminal occlusion, but fibro-obliteration still developed by 28 days after transplantation.

Conclusions: Endogenous adenosine signals through the A_2AR to attenuate inflammatory and immune factors involved in BO development. Synthetic A_2AR agonists may provide a novel treatment strategy to prevent BO.